WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs - the same ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

London’s Guy’s Hospital has become one of the first to prescribe weight-loss jabs. The central London hospital, part of the ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The US plans to slash the price it pays for Novo Nordisk's Ozempic and Wegovy, the latest drugs to be targeted under legislation that's expected save the government more than $200 billion over a ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Investing.com -- Shares of Novo Nordisk (NYSE: NVO) fell 3.6% on Friday after the U.S. Department of Health and Human ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

There are around 80 patients who are currently prescribed weight-loss jab Wegovy solely for obesity treatment and the GHA is looking to review guidance for the new highly-effective drug Mounjaro with ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...